Ardila Jurado Elena, Sturm Veit, Brugger Florian, Nedeltchev Krassen, Arnold Marcel, Bonati Leo H, Carrera Emmanuel, Michel Patrik, Cereda Carlo W, Bolognese Manuel, Albert Sylvan, Medlin Friedrich, Berger Christian, Schelosky Ludwig, Renaud Susanne, Niederhauser Julien, Bonvin Christophe, Mono Marie-Luise, Rodic Biljana, Tarnutzer Alexander A, Schwegler Guido, Salmen Stephan, Luft Andreas R, Peters Nils, Vehoff Jochen, Kägi Georg
Department of Neurology and Stroke Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Front Neurol. 2022 May 23;13:888456. doi: 10.3389/fneur.2022.888456. eCollection 2022.
Central retinal artery occlusion (CRAO) often leads to permanent monocular blindness. Hence, early recognition and rapid re-perfusion is of paramount importance. This study aims to describe prehospital pathways in CRAO compared to stroke and study the knowledge about CRAO.
(1) Description of baseline characteristics, prehospital pathways/delays, and acute treatment (thrombolysis/thrombectomy vs. standard of care) of patients with CRAO and ischemic stroke registered in the Swiss Stroke Registry. (2) Online survey about CRAO knowledge amongst population, general practitioners (GPs) and ophthalmologists in Eastern Switzerland.
Three hundred and ninety seven CRAO and 32,816 ischemic stroke cases were registered from 2014 until 2019 in 20 Stroke Centers/Units in Switzerland. In CRAO, 25.6% arrived at the hospital within 4 h of symptom onset and had a lower rate of emergency referrals. Hence, the symptom-to-door time was significantly longer in CRAO compared to stroke (852 min. vs. 300 min). The thrombolysis/thrombectomy rate was 13.2% in CRAO and 30.9% in stroke. 28.6% of the surveyed population recognized CRAO-symptoms, 55.4% of which would present directly to the emergency department in contrast to 90.0% with stroke symptoms. Almost 100% of the ophthalmologist and general practitioners recognized CRAO as a medical emergency and 1/3 of them considered IV thrombolysis a potentially beneficial therapy.
CRAO awareness of the general population and physician awareness about the treatment options as well as the non-standardized prehospital organization, seems to be the main reason for the prehospital delays and impedes treating CRAO patients. Educational efforts should be undertaken to improve awareness about CRAO.
视网膜中央动脉阻塞(CRAO)常导致永久性单眼失明。因此,早期识别和快速再灌注至关重要。本研究旨在描述与中风相比CRAO的院前路径,并研究关于CRAO的知识。
(1)描述瑞士中风登记处登记的CRAO和缺血性中风患者的基线特征、院前路径/延误以及急性治疗(溶栓/取栓与标准治疗)情况。(2)对瑞士东部的普通人群、全科医生(GPs)和眼科医生进行关于CRAO知识的在线调查。
2014年至2019年期间,瑞士20个中风中心/科室登记了397例CRAO和32816例缺血性中风病例。在CRAO患者中,25.6%在症状发作后4小时内到达医院,急诊转诊率较低。因此,与中风相比,CRAO的症状到入院时间明显更长(852分钟对300分钟)。CRAO的溶栓/取栓率为13.2%,中风为30.9%。28.6%的被调查人群能识别CRAO症状,其中55.4%会直接前往急诊科,而中风症状患者这一比例为90.0%。几乎100%的眼科医生和全科医生认识到CRAO是一种医疗急症,其中三分之一认为静脉溶栓是一种可能有益的治疗方法。
普通人群对CRAO的认知、医生对治疗选择的认知以及院前组织的不标准化,似乎是院前延误的主要原因,并阻碍了对CRAO患者的治疗。应开展教育工作以提高对CRAO的认识。